A D-dimer of 1.35 µg/mL is elevated and requires further diagnostic workup based on clinical probability assessment—it cannot exclude venous thromboembolism (VTE) but also does not confirm it.
Clinical Significance
The interpretation of your D-dimer level of 1.35 µg/mL depends entirely on the pretest clinical probability of pulmonary embolism (PE) or deep vein thrombosis (DVT). This value is above the standard cutoff of 0.5 µg/mL (500 ng/mL), making it abnormal, but the magnitude matters for risk stratification 1.
Key Context for Interpretation:
- D-dimer is highly sensitive but poorly specific for VTE—it can be elevated in many non-thrombotic conditions (infection, inflammation, malignancy, pregnancy, recent surgery, advanced age) 2, 3
- A D-dimer of 1.35 µg/mL falls in the lower-moderate elevation range, where the positive predictive value for PE is approximately 8-16% based on research showing increasing likelihood with higher values 4
- Age matters: If you are over 50 years old, an age-adjusted cutoff (age × 10 µg/L) should be considered. For example, if you're 60 years old, your adjusted cutoff would be 600 µg/L (0.6 µg/mL), making 1.35 µg/mL still elevated but less dramatically so 1, 5, 6, 7
Diagnostic Algorithm
Step 1: Assess Clinical Probability
You must first determine your pretest probability using a validated tool (Wells score, Geneva score, or clinical gestalt) 1:
Low Probability:
- Apply PERC criteria first (if all 8 criteria met, no further testing needed) 5
- If PERC not met: D-dimer of 1.35 µg/mL is positive → proceed to imaging (CTPA or V/Q scan) 1, 5
Intermediate Probability:
- D-dimer of 1.35 µg/mL is positive → proceed to imaging (CTPA or V/Q scan) 1
- Consider age-adjusted cutoff if over 50 years 1, 6, 7
High Probability:
- Skip D-dimer entirely and proceed directly to imaging 1, 5
- A normal D-dimer does not safely exclude PE in high-probability patients 1
Step 2: Imaging Decision
For suspected PE:
- CTPA (CT pulmonary angiography) is the preferred diagnostic test when available and no contraindication to contrast exists 1
- V/Q scan if CTPA contraindicated 1
- If high or intermediate clinical probability, initiate anticoagulation while awaiting imaging 1
For suspected DVT:
- Compression ultrasonography (CUS) of lower extremities 1, 7
- A positive proximal DVT on ultrasound confirms VTE and obviates need for further PE imaging 1
Step 3: Management Based on Imaging
If imaging confirms PE/DVT:
- Initiate therapeutic anticoagulation
- Assess PE severity for risk stratification 1
If imaging is negative:
- In low/intermediate probability patients: VTE is excluded, no anticoagulation needed 1
- In high probability patients with negative CTPA: consider additional testing 1
Critical Pitfalls to Avoid
Never use D-dimer alone to diagnose VTE—it only helps exclude disease when negative in appropriate clinical contexts 2, 3
Never skip imaging in high-probability patients even with elevated D-dimer—proceed directly to CTPA 1, 5
Never ignore age adjustment in patients >50 years—this significantly improves specificity without losing safety 1, 6, 7
Never order D-dimer in hospitalized patients or those with obvious alternative explanations for elevation (recent surgery, active cancer, pregnancy)—specificity becomes too poor 2, 3
Never delay anticoagulation in intermediate/high probability patients while awaiting imaging—start treatment immediately 1
Bottom Line for Your Value of 1.35 µg/mL
This elevated D-dimer cannot exclude VTE and requires clinical probability assessment followed by appropriate imaging in most scenarios. The 2019 ESC Guidelines provide the strongest framework: combine this result with validated clinical prediction tools, and if you have low or intermediate probability, proceed to CTPA or lower extremity ultrasound 1. The magnitude of 1.35 µg/mL suggests moderate elevation, which research shows carries approximately 8-16% likelihood of PE if imaging is performed 4, but this must be interpreted in your specific clinical context.